Aerium Therapeutics

Adagio Therapeutics

This biopharmaceutical company develops monoclonal antibody therapies for the prevention and treatment of viral respiratory diseases, primarily serving immunocompromised patients.

Adagio tx

This biopharmaceutical company develops monoclonal antibody treatments and prophylactics for infectious viral diseases to protect patients against coronaviruses and their evolving variants.

Aiolos Bio

This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.

Invivyd

Invivyd develops monoclonal antibody therapies to protect immunocompromised patients from serious viral infectious diseases, including COVID-19 and measles.

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.

Halo Therapeutics

This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.

Radiant Biotherapeutics

This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.

CoVBio

The company develops broad-spectrum vaccines and therapeutic antibodies to protect the global population against coronaviruses and other respiratory viral infections.